Indications and uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
tablet melts in mouth. Can be taken with or without water. Age Dose adults and children 6 years and over 1 tablet daily; do not use more than 1 tablet daily children under 6 ask a doctor consumers who have liver or kidney disease ask a doctor
phenylketonurics: contains phenylalanine 8.4 mg per tablet store at 20-25°C (68-77°F) keep in a dry place
Drug Facts
Loratadine 10 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
Do not useif you have ever had an allergic reaction to this product or any of its ingredients
Ask a doctor before use if you haveliver or kidney disease. Your doctor should determine if you need a different dose.
When using this productdo not use more than directed. Taking more than recommended may cause drowsiness.
Stop use and ask a doctor ifan allergic reaction to this product occurs. Seek medical help right away.
If pregnant or breast-feeding,ask a health professional before use.
Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.
| Age | Dose |
|---|---|
| adults and children 6 years and over | 1 tablet daily; do not use more than 1 tablet daily |
| children under 6 | ask a doctor |
| consumers who have liver or kidney disease | ask a doctor |
anhydrous citric acid, aspartame, colloidal silicon dioxide, corn syrup solids, crospovidone, magnesium stearate, mannitol, microcrystalline cellulose, modified starch, natural and artificial flavors, sodium bicarbonate
Call 1-800 ALAVERT (1-800-252-8378)weekdays 9 AM to 5 PM EST
Distributed by: Foundation Consumer Brands, LLC
Pittsburgh, PA 15212
TASTES GREAT!
Melts in your
Mouth!
Compare to Claritin
®†
& SAVE!
allergy
ALAVERT ®
Loratadine Orally Disintegrating Tablet, 10 mg
Antihistamine
Non-Drowsy*Allergy Relief
24
HOUR
Relief of
Fresh Mint
60
Orally
Disintegrating
Tablets
*When taken as directed. See Drug Facts Panel.

| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 351855 | Alavert 10 MG 24HR Disintegrating Oral Tablet | PSN | 3 |
| 311373 | loratadine 10 MG 24HR Disintegrating Oral Tablet | PSN | 3 |
| 351855 | loratadine 10 MG Disintegrating Oral Tablet [Alavert] | SBD | 3 |
| 311373 | loratadine 10 MG Disintegrating Oral Tablet | SCD | 3 |
| 351855 | 24 HR Alavert 10 MG Disintegrating Oral Tablet | SY | 3 |
| 351855 | Alavert 10 MG Disintegrating Oral Tablet | SY | 3 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80070-120-60 | AlavertAllergy | 1 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 1 | 3 | |
| 80070-120-60 | AlavertAllergy | 60 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 60 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 80070-120 | 80070-120-60 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| ASPARTAME | Z0H242BBR1 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| CORN SYRUP | 9G5L16BK6N | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| CROSPOVIDONE (120 .MU.M) | 68401960MK | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MANNITOL | 3OWL53L36A | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| SODIUM BICARBONATE | 8MDF5V39QO | IACT |
| LORATADINE | 7AJO3BO7QN | ACTIB |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021375-001 | ALAVERT | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021375-001 | ALAVERT | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2002-12-19 | 3a93d1ddd44b… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4b819711-23f5-d6a6-e063-6394a90a2439 | 039ea563-9796-4270-b84a-50dd25a9d976 | 2026-02-23 | Warnings | 4b819711-23f5-d6a6-e063-6394a90a2439 039ea563-9796-4270-b84a-50dd25a9d976 |
Adverse event summaries are temporarily unavailable. Other product information remains available.